Related Experiment Video
Updated: Dec 7, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prediction of adverse clinical outcomes in patients with coronavirus disease 2019
Si Shi1, Xiaohui Liu1, Jinling Xiao1
1The Respiratory Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Insights
High levels of interleukin-6 and neutrophils-to-lymphocytes ratio (NLR) at admission can predict poor outcomes in COVID-19 patients. These findings aid in early identification and intervention to reduce mortality.
Area of Science:
- Medical laboratory science
- Infectious disease research
- Critical care medicine
Background:
- Coronavirus disease (COVID-19) presents with diverse clinical manifestations.
- Identifying early predictors of severe outcomes is crucial for patient management.
- Laboratory findings offer potential insights into disease severity.
Purpose of the Study:
- To investigate blood and biochemical laboratory findings in COVID-19 patients.
- To identify predictors of poor prognosis in COVID-19.
- To analyze the utility of specific biomarkers for outcome prediction.
Main Methods:
- Retrospective analysis of clinical and laboratory data from 87 COVID-19 patients.
- Division of patients into adverse prognosis (ICU admission or death) and non-adverse prognosis groups.
- Univariate and multivariate analyses to identify significant predictors of poor outcome.
Main Results:
- Univariate analysis identified age, WBC count, neutrophil count, lymphocyte count, NLR, IL-6, AGR, albumin, LDH, GGT, and glucose as significant predictors.
- Multivariate analysis revealed NLR (OR=2.741) and IL-6 (OR=1.405) as independent predictors of poor outcome.
- ROC curve analysis showed high AUC values for NLR (0.883) and IL-6 (0.852).
Conclusions:
- Elevated NLR and IL-6 levels upon admission are significant predictors of poor outcomes in COVID-19.
- These biomarkers can facilitate timely identification of high-risk patients.
- Early intervention based on these predictors may help reduce COVID-19 patient mortality.
Objective:
This study aims to investigate blood and biochemical laboratory findings in patients with coronavirus disease (COVID-19) and analyze the potential predictors of poor outcome in patients with COVID-19.
Methods:
The clinical, laboratory, and outcome data of 87 patients with COVID-19 were collected and retrospectively analyzed. Only data collected at the time of admission were used in the analysis for predictors of poor outcome. These patients were divided into two groups: the adverse prognosis group (36 patients) and the non-adverse prognosis group (51 patients). The adverse prognosis of COVID-19 patients was defined as admission to the intensive care unit or death.
Results:
On the univariate analysis, age, white blood cell (WBC) count, neutrophil counts, lymphocytes count, neutrophils-to-lymphocytes ratio (NLR), interleukin-6, albumin-to-globulin ratio (AGR), albumin, lactate dehydrogenase, glutamyl transpeptidase, and blood glucose were found to be the significant predictors. On the multivariate analysis, the predictors of poor outcome of patients with COVID-19 were NLR (OR = 2.741, [95% CI = 1.02 ~ 7.35], P = .045) and IL-6 (OR = 1.405, [95% CI = 1.04 ~ 1.89, P = .025]). The receiver operating characteristic (ROC) curve revealed that the AUC of NLR, interleukin-6, pneumonia severity index (PSI) score, and Confusion-Urea-Respiratory Rate-Blood pressure-65 (CURB-65) score were 0.883, 0.852, 0.824, and 0.782, respectively.
Conclusion:
High interleukin-6 (6 pg/mL, cuff value) and NLR (4.48, cuff value) can be used to predict poor outcomes in patients with COVID-19 on admission, thus can serve as a beneficial tool for timely identifying COVID-19 patients prone to poor outcome and reduce patient mortality through early intervention.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Coronary Artery Disease III: Clinical Manifestations
Predicting Reaction Outcomes
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

